Olanzapine may increase the risk of death in older adults with psychosis (loss of touch with reality) related to dementia. Olanzapine is not approved for use in this group of people. For more ...

Please provide your email address to receive an email when new articles are posted on . Low-dose olanzapine appeared noninferior to standard dose for controlling chemotherapy-induced nausea and ...

Schizophrenia and bipolar I disorder are two conditions that have many differences between them. A class of medicines called antipsychotics can be used to treat both conditions but may cause unwanted ...

Yoga-based supportive care for patients with head and neck cancer undergoing radiotherapy: Results of a three-arm randomized controlled trial. This is an ASCO Meeting Abstract from the 2023 ASCO ...

As a leader in neuroscience, Teva is committed to researching new treatment innovations that may help address unmet needs in treating schizophrenia, including TEV-‘749 Currently, there is no ...

TEL AVIV, Israel & NEW YORK--(BUSINESS WIRE)--Teva Pharmaceuticals International GmbH, a subsidiary of Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) and Royalty Pharma plc (Nasdaq: RPRX), ...

More than 92% of schizophrenia patients taking Olanzapine LAI in the Phase 3 SOLARIS survey were satisfied or very satisfied with the initiation regimen, dosing schedule and trial medication 1.